Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori.

Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S, Guiney DG.

Infect Immun. 2007 May;75(5):2408-14. Epub 2007 Mar 12.

2.

Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection.

Nemati M, Larussa T, Khorramdelazad H, Mahmoodi M, Jafarzadeh A.

Life Sci. 2017 Jun 1;178:17-29. doi: 10.1016/j.lfs.2017.04.006. Epub 2017 Apr 18. Review.

PMID:
28427896
3.

Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways.

Echizen K, Hirose O, Maeda Y, Oshima M.

Cancer Sci. 2016 Apr;107(4):391-7. doi: 10.1111/cas.12901. Epub 2016 Mar 18. Review. Erratum in: Cancer Sci. 2016 Jul;107(7):1059.

4.

Role of Toll-like receptors in Helicobacter pylori infection and immunity.

Smith SM.

World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):133-46. doi: 10.4291/wjgp.v5.i3.133. Review.

5.

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis.

Roshan MH, Tambo A, Pace NP.

Int J Inflam. 2016;2016:1532832. Epub 2016 Oct 4. Review.

6.

[The chemical structure of Helicobacter pylori lipopolysaccharide and innate immune response].

Arabski M, Koza A, Kaca W.

Postepy Hig Med Dosw (Online). 2008 Jun 12;62:289-96. Review. Polish.

7.

Pattern-recognition receptors and gastric cancer.

Castaño-Rodríguez N, Kaakoush NO, Mitchell HM.

Front Immunol. 2014 Jul 22;5:336. doi: 10.3389/fimmu.2014.00336. eCollection 2014. Review.

8.

MyD88 and its divergent toll in carcinogenesis.

Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G.

Trends Immunol. 2013 Aug;34(8):379-89. doi: 10.1016/j.it.2013.03.008. Epub 2013 May 7. Review.

9.

Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise.

Gobert AP, Wilson KT.

Free Radic Biol Med. 2017 Apr;105:16-27. doi: 10.1016/j.freeradbiomed.2016.09.024. Epub 2016 Sep 25. Review.

PMID:
27682363
10.

Helicobacter pylori and neurological diseases: Married by the laws of inflammation.

Alvarez-Arellano L, Maldonado-Bernal C.

World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):400-4. doi: 10.4291/wjgp.v5.i4.400. Review.

11.

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets.

Barratt-Due A, Pischke SE, Nilsson PH, Espevik T, Mollnes TE.

J Leukoc Biol. 2017 Jan;101(1):193-204. doi: 10.1189/jlb.3VMR0316-132R. Epub 2016 Aug 31. Review.

12.

Morphology and Ultrastructure.

O'Rourke J, Bode G.

In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 6.

Supplemental Content

Support Center